Publikationen, an denen er mitarbeitet Ramón Gomis (34)

2021

  1. Fatty liver index as a predictor for type 2 diabetes in subjects with normoglycemia in a nationwide cohort study

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Incidence and regression of metabolic syndrome in a representative sample of the Spanish population: Results of the cohort di@bet.es study

    BMJ Open Diabetes Research and Care, Vol. 8, Núm. 1

  2. Incidence of diabetes mellitus in Spain as results of the nation-wide cohort di@bet.es study

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Ambient temperature and prevalence of diabetes and insulin resistance in the Spanish population: Di@bet.es study

    European Journal of Endocrinology, Vol. 180, Núm. 5, pp. 275-282

2016

  1. Cardiovascular and other outcomes postintervention with insulin glargine and omega-3 fatty acids (ORIGINALE)

    Diabetes Care, Vol. 39, Núm. 5, pp. 709-716

  2. Low physical activity and its association with diabetes and other cardiovascular risk factors: A nationwide, population-based study

    PLoS ONE, Vol. 11, Núm. 8

  3. Prevalencia, diagnóstico, tratamiento y control de la hipertensión arterial en España. Resultados del estudio Di@bet.es

    Revista Espanola de Cardiologia, Vol. 69, Núm. 6, pp. 572-578

2015

  1. Estimating cardiovascular risk in Spain by the European guidelines on cardiovascular disease prevention in clinical practice

    Revista Espanola de Cardiologia, Vol. 68, Núm. 5, pp. 417-425

2014

  1. Ambient temperature and prevalence of obesity in the spanish population: The di@bet.es study

    Obesity, Vol. 22, Núm. 11, pp. 2328-2332

  2. Modifications of the homeostasis model assessment of insulin resistance index with age

    Acta Diabetologica, Vol. 51, Núm. 6, pp. 917-925

  3. Prevalence of plasma lipid abnormalities and its association with glucose metabolism in Spain: The di@bet.es study

    Clinica e Investigacion en Arteriosclerosis, Vol. 26, Núm. 3, pp. 107-114

  4. Prevalence of plasma lipid abnormalities and its association with glucose metabolism in Spain: The di@bet.es study

    Clínica e investigación en arteriosclerosis, Vol. 26, Núm. 3, pp. 107-114

  5. Prevalencia de obesidad, diabetes mellitus y otros factores de riesgo cardiovascular en Andalucía. Comparación con datos de prevalencia nacionales. Estudio Di@bet.es

    Revista Espanola de Cardiologia, Vol. 67, Núm. 6, pp. 442-448

  6. The efficiency of telemedicine to optimize metabolic control in patients with type 1 diabetes mellitus: Telemed study

    Diabetes Technology and Therapeutics, Vol. 16, Núm. 7, pp. 435-441

  7. Variable patterns of obesity and cardiometabolic phenotypes and their association with lifestyle factors in the Di@bet.es study

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 24, Núm. 9, pp. 947-955

2013

  1. Consumo de fármacos relacionados con el tratamiento de la diabetes mellitus y otros factores de riesgo cardiovascular en la población española. Estudio Di@bet.es

    Revista Espanola de Cardiologia, Vol. 66, Núm. 11, pp. 854-863

  2. Factors affecting levels of urinary albumin excretion in the general population of Spain: The Di@bet.es study

    Clinical Science, Vol. 124, Núm. 4, pp. 269-277

  3. Factors determining high-sensitivity C-reactive protein values in the Spanish population. Di@bet.es study

    European Journal of Clinical Investigation, Vol. 43, Núm. 1, pp. 1-10

  4. Mediterranean diet adherence in individuals with prediabetes and unknown diabetes: The Di@bet.es study

    Annals of Nutrition and Metabolism, Vol. 62, Núm. 4, pp. 339-346

  5. Olive oil has a beneficial effect on impaired glucose regulation and other cardiometabolic risk factors. Di@bet.es study

    European Journal of Clinical Nutrition, Vol. 67, Núm. 9, pp. 911-916